The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-((1R,2S,5S)-2-Benzyl-3-azabicyclo[3.1.0]hexan-3-yl)-4-morpholinopyridin-2(1H)-one ID: ALA4874640
PubChem CID: 156458424
Max Phase: Preclinical
Molecular Formula: C21H25N3O2
Molecular Weight: 351.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=c1cc(N2CCOCC2)cc(N2C[C@H]3C[C@H]3[C@@H]2Cc2ccccc2)[nH]1
Standard InChI: InChI=1S/C21H25N3O2/c25-21-13-17(23-6-8-26-9-7-23)12-20(22-21)24-14-16-11-18(16)19(24)10-15-4-2-1-3-5-15/h1-5,12-13,16,18-19H,6-11,14H2,(H,22,25)/t16-,18-,19+/m1/s1
Standard InChI Key: FZLLSBHPQYLGLH-QRQLOZEOSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
32.1181 -1.2959 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.1181 -2.1173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8275 -2.5259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5369 -2.1173 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.5369 -1.2959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8275 -0.8832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2477 -2.5299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2446 -3.3522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9476 -3.7617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6624 -3.3576 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.6656 -2.5353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9539 -2.1171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9423 -4.5789 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.3756 -2.1308 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.1184 -2.4652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4639 -1.3164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2843 -3.2654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0602 -3.5218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2245 -4.3221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9996 -4.5786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6105 -4.0345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4412 -3.2308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6662 -2.9780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2641 -1.1510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6664 -1.8578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0774 -1.1560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3708 -2.2658 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
37.2565 -0.3302 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 2 0
7 12 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
4 7 1 0
9 13 2 0
11 14 1 0
14 15 1 0
15 25 1 0
24 16 1 0
16 14 1 0
15 17 1 6
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
25 24 1 0
25 26 1 0
24 26 1 0
25 27 1 6
24 28 1 6
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 351.45Molecular Weight (Monoisotopic): 351.1947AlogP: 2.28#Rotatable Bonds: 4Polar Surface Area: 48.57Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.86CX Basic pKa: 5.02CX LogP: 2.19CX LogD: 2.19Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.92Np Likeness Score: -0.24
References 1. Van de Poël A, Toledo-Sherman L, Breccia P, Cachope R, Bate JR, Angulo-Herrera I, Wishart G, Matthews KL, Martin SL, Peacock M, Barnard A, Cox HC, Jones G, McAllister G, Vater H, Esmieu W, Clissold C, Lamers M, Leonard P, Jarvis RE, Blackaby W, Eznarriaga M, Lazari O, Yates D, Rose M, Jang SW, Muñoz-Sanjuan I, Dominguez C.. (2021) Structure-Based Exploration of Selectivity for ATM Inhibitors in Huntington's Disease., 64 (8.0): [PMID:33783225 ] [10.1021/acs.jmedchem.1c00114 ]